Skin deep? At Estée Lauder, beauty science runs deeper
By TOM MARINER // Of course you know the multinational powerhouse, but that’s not how The Estée Lauder Companies began. Queens-born Estée Lauder and her husband, Joseph, launched the small…
biotechnology
Same problems, new solutions in Molloy ‘Talent’ program
By GREGORY ZELLER // Academic and business leaders are uniting on a mission to upskill regional talent. The Molloy Talent Solutions Summit, scheduled for Tuesday at the Rockville Centre university,…
‘Bioprinting’ breakthrough could reset biotech research
By GREGORY ZELLER // Researchers have taken a big step forward in “bioprinting” – the science of fabricating living biological structures. Creating fully functional replacements for malfunctioning organs or missing…
Centuries later, the Town of Islip is always on the move
By TOM MARINER // As I prepare to board a Long Island Rail Road train at Ronkonkoma Station for a quick journey into the city and another hot-button pharmaceutical conference,…
The Debrief: At SBU, an innovative take on eco-dev
As Stony Brook University’s first-ever chief innovation officer, Michael Kinch holds a uniquely influential position in one of the region’s biggest and busiest commercialization operations. Wielding an impressive résumé…
With $150M ante, Albany all-in on LI’s BioGenesis Park
By GREGORY ZELLER // A whopping nine-digit state investment will spark a groundbreaking Cell and Gene Therapy innovation hub on Long Island. Albany is anteing up $150 million – including…
Embracing the past, seizing the future at Enzo Biochem
By TOM MARINER // Farmingdale’s Enzo Biochem has been a prescient predictor of biotechnology advances for nearly five decades – forever innovating, protecting and delivering the “right” bio products at…
Study gives science the upper hand on Lyme disease
By GREGORY ZELLER // Scientists have deciphered the genetics of dozens of bacteria known to transmit Lyme disease – a major step toward new treatments for the world’s most prevalent…
State nod marks another win for ‘precision medication’
By GREGORY ZELLER // An accomplished Long Island biotech with a penchant for polymerase chain reaction-based DNA technologies has earned state approvals for a cutting-edge pharmacogenomic testing service. Pharmacogenomics, the…
In little Leo, the face of future personalized medicine
By GREGORY ZELLER // A California biotech has leveraged artificial intelligence and other cutting-edge tools in a perilous rescue mission focused on a 2-year-old Setauket boy born with an unusual…
CSHL, Northwell extend cancer-fighting ‘affiliation’
By GREGORY ZELLER // Two of Long Island’s cornerstone bioscience institutions have extended a longstanding – and highly successful – collaboration. Cold Spring Harbor Laboratory and New Hyde Park-based Northwell…
How to stop COVID, and maybe whatever comes next
By GREGORY ZELLER // The latest DNA-based advance by a progressive Long Island biotech goes where other biochemists have gone before – but also blazes a trail for new vaccination…
Familiar face takes the reins at FSC’s Bioscience Park
By GREGORY ZELLER // Broad Hollow Bioscience Park’s new head honcho is an old friend of regional commercialization. Dan Polner, most recently the incubator advocate for Stony Brook University’s Office…
With Nassau in the PILOT seat, Acupath thinks bigger
By GREGORY ZELLER // A veteran Long Island biotech that found new footing during the COVID crisis is on the verge of a major expansion, with a tip of the…
LI biotech gears up to help shoot down forced labor
By GREGORY ZELLER // A new federal law governing Chinese imports bodes very well for a leading Long Island innovator. Stony Brook-based Applied DNA Sciences – a DNA-based supply-chain authenticator that’s…